+11.7%
CVS vs ENB
+53.3%
-41.7%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | ENB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +4.4% | +0.8% | +3.7% | +4.2% |
| 7D | -2.6% | -2.4% | -0.2% | -1.8% |
| 30D | +4.0% | +2.5% | +1.6% | +3.1% |
| 3M | -6.3% | -5.8% | -0.5% | -4.5% |
| 6M | -0.4% | -8.5% | +8.1% | +2.5% |
| YTD | +15.6% | +3.9% | +11.7% | +13.6% |
| 1Y | +18.3% | +3.7% | +14.6% | +16.3% |
| 3Y | +47.3% | +70.1% | -22.8% | +18.4% |
| All | +11.7% | +53.3% | -41.7% | -3.5% |
Cumulative growth
Daily Returns
Daily percentage return beside ENB.
Daily Out/Under-Performance
Portfolio return minus ENB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded ENB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling